Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz
Gewählte Publikation:
Keeling, IM; Obermayr, RP; Schneider, B; Spieckermann, PG.
Postischemic cardiac function recovery in the isolated rat heart: effects of adenosine deaminase and nucleoside transport inhibition.
Langenbecks Arch Surg. 2000; 385(8):531-537
Doi: 10.1007%2Fs004230000168
Web of Science
PubMed
FullText
FullText_MUG
- Führende Autor*innen der Med Uni Graz
- Keeling Ingeborg
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Abstract:
- BACKGROUND AND AIMS: This study assessed the cardioprotective effects of inhibitors of adenosine metabolism in an isolated perfused rat heart model. Specifically, we studied the adenosine deaminase inhibitor erythro-9-(2-hydroxy-3-nonyl)-adenine and the selective nucleoside transport inhibitor S-(p-nitrobenzyl)-6-thioinosine, in terms of their potential to enhance protection when added to Bretschneider's cardioplegic solution. METHODS: Rat hearts were infused for 5 min with Krebs-Henseleit buffer solution (group 1), Bretschneider's cardioplegic solution (group 2), Bretschneider's cardioplegic solution with the addition of 25 microM erythro-9-(2-hydroxy-3-nonyl)-adenine and 5 microM S-(p-nitrobenzyl)-6-thioinosine (group 3), and Bretschneider's cardioplegic solution with the addtion of 25 microM erythro-9-(2-hydroxy-3-nonyl)-adenine only (group 4). After cardioplegic arrest and 45 min of ischemic storage at 25 degrees C, the functional recovery of the hearts was tested during 15 min of Langendorff reperfusion and then 45 min of working heart reperfusion. RESULTS: In relation to the cardioprotective effects of Bretschneider's cardioplegic solution alone, we observed an improved recovery of hemodynamic function of the hearts with the addition of both erythro-9-(2-hydroxy-3-nonyl)-adenine and S-(p-nitrobenzyl)-6-thioinosine. However, the myocardial adenosine triphosphate (ATP) concentration remained unchanged. Bradycardia observed under the addition of erythro-9-(2-hydroxy-3-nonyl)-adenine alone was prevented by the addition of S-(p-nitrobenzyl)-6-thioinosine. CONCLUSION: A combination of both substances may be tested further for cardiac preservation, as it might improve the recovery from ischemia at moderate temperatures.
- Find related publications in this database (using NLM MeSH Indexing)
- Adenine - analogs and derivatives
- Adenosine Deaminase - metabolism
- Affinity Labels - pharmacology
- Animals - pharmacology
- Cardioplegic Solutions - pharmacology
- Disease Models, Animal - pharmacology
- Enzyme Inhibitors - pharmacology
- Glucose - pharmacology
- Male - pharmacology
- Mannitol - pharmacology
- Myocardial Reperfusion Injury - enzymology
- Myocardium - enzymology
- Potassium Chloride - pharmacology
- Procaine - pharmacology
- Rats - pharmacology
- Rats, Sprague-Dawley - pharmacology
- Thioinosine - analogs and derivatives
- Find related publications in this database (Keywords)
- erythro-9-(2-hydroxy-3-nonyl)-adenine (EHNA) S-(p-nitrobenzyl)-6-thioinosine (NBMPR)
- Bretschneider's cardioplegic solution
- ischemia-reperfusion injury
- working-heart model for rats